Vasomotion has been defined as the rhythmic oscillation of the vascular tone, involved in the control of the blood flow and subsequent tissue perfusion. Our aims were to study the incidence of vasomotion in the human internal thoracic artery and the correlation of this phenomenon with the clinical profile and parameters of vascular reactivity. In our study, vasomotion was elicited with a single-dose contractile stimulation of noradrenaline (10 M) in internal thoracic artery segments, from patients undergoing coronary artery bypass grafting, mounted in tissue organ bath chambers. The incidence was 29.1%. Vessel samples with vasomotion presented significantly higher contractility in response to both potassium chloride (maximal response or E max of 7.65 ± 5.81 mN versus 4.52 ± 3.73 mN in control vessels, P = 0.024) and noradrenaline (E max of 7.60 ± 5.93 mN versus 2.96 ± 4.41 mN in control vessels, P < 0.001). Predictive modelling through multivariable logistic regression analysis showed that female sex (odds ratio = 9.82) and increasing maximal response to noradrenaline (odds ratio = 1.19, per 1 mN increase) were associated with a higher probability of the occurrence of vasomotion, whereas increasing kidney function (expressed as estimated glomerular filtration rate) was associated with a lower probability (odds ratio = 0.97, per 1 ml min −1 (1.73 m) −2 ]. Our results provide a characterization of the phenomenon of vasomotion in the internal thoracic artery and suggest that vasomotion might be associated with endothelial dysfunction settings, as determined by a multivariable analysis approach. Considering the associations observed in our results, vasomotion might be a signal of functional impairment and not of integrity.
INTRODUCTION
Vasomotion has been defined as the rhythmic oscillation of the vascular tone that originates flowmotion, i.e. the oscillation of blood flow into an organ. Hence, it has been suggested to be important for optimal blood flow and tissue perfusion. However, these findings require further experimental verification (Aalkjaer, Boedtkjer, & Matchkov, 2011) .
Although other elements may be involved, this behaviour has been correlated with oscillations in [Ca 2+ ] i in the vascular smooth muscle c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society cells (Aalkjaer & Nilsson, 2005; Aalkjaer et al., 2011; Broegger et al., 2011; Chen et al., 2010; Haddock & Hill, 2005) .
Several studies have shown this phenomenon both in human and in animal vessels, and its correlation with disease states has also been studied previously. In fact, previous studies showed an altered pattern and/or decreased prevalence of vasomotion both in human (Benbow et al., 1995; Stansberry et al., 1996) and in animal (Bouskela, Cyrino, & Wiernsperger, 1997; Renaudin, Michoud, Lagarde, & Wiernsperger, 1999 ) models of diabetes and in animal (Boegehold, 1993; Chen et al., 2010; Lefer, Lynch, Lapinski, & Hutchins, 1990) and human (Aalkjaer
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• What is the central question of this study?
Vasomotion has been viewed as a rhythmic oscillation of the vascular tone that is physiologically important for optimal tissue perfusion. Also, it has been studied primarily in the microcirculation. However, the precise underlying mechanisms and the physiological significance remain unknown.
• What is the main finding and its importance?
Vasomotion is not specific to the microcirculation, as shown by our findings. In human arteries from patients undergoing cardiac surgery, an increased incidence was associated with endothelial dysfunction settings.
Therefore, this oscillatory behaviour might be a signal of functional impairment and not of integrity.
et al., 1985; Rossi, Carpi, Di Maria, Galetta, & Santoro, 2006 ) models of arterial hypertension.
Although this phenomenon has been shown in several vascular beds, several questions remain unanswered, namely the precise underlying mechanisms, the physiological significance and the potential pathophysiological consequences (Aalkjaer et al., 2011) . Also, a solid correlation with the clinical profile and cardiovascular risk factors is yet to be achieved. Thus, the study of the prevalence of vasomotion in disease states could provide a better insight into the underlying mechanisms (Aalkjaer et al., 2011) .
In this context, we primarily aimed to study the incidence of vasomotion and the correlation of this phenomenon with the clinical profile and parameters of vascular reactivity. The left internal thoracic artery (ITA), harvested from patients undergoing coronary artery bypass grafting, was used as a vascular reactivity model owing to its higher functional and structural integrity compared with other human vessels (Fonseca, Antunes, & Cotrim, 2014 , 2017a .
METHODS
Ethical approval
All experiments were performed on left ITA distal samples harvested from patients undergoing coronary artery bypass grafting, and no procedures were carried out on the subjects included in the study.
Written informed consent was obtained from each patient, and the experiments were carried out with approval from the research ethics committees of the Faculty of Medicine of University of Coimbra and the University Hospital of Coimbra (Coimbra, Portugal), with the references CE-107/2014 and PC-388/08, respectively. The study was conducted in accordance with the Declaration of Helsinki and was not registered in any research database.
Preoperative clinical variable definition
Smoking history was defined as a history of consumption of any form of tobacco (cigarettes, cigars, tobacco chew, smoking pipe or others).
Arterial hypertension was defined as systolic and diastolic blood pressure exceeding 140 and 90 mmHg, respectively, or a history of high blood pressure or need for antihypertensive drugs. Diabetes mellitus was defined as a history of diabetes and current treatment with either insulin or oral drugs. Dyslipidaemia was defined as the presence or absence of a history of dyslipidaemia diagnosed and/or treated by a physician. Peripheral vascular disease was defined as claudication either with exertion or at rest; amputation for arterial insufficiency; aorto-iliac occlusive disease reconstruction; peripheral vascular bypass surgery, angioplasty or stent; documented abdominal aortic aneurysm, repair or stent; or non-invasive carotid test with >75% occlusion. Cerebrovascular disease was defined as unresponsive coma for >24 h, cerebrovascular accident or transient ischaemic attack. Kidney function was evaluated by the value of estimated glomerular filtration rate (eGFR), from the modification of diet in renal disease (MDRD) formula (Levey et al., 1999) . The highest serum concentration of creatinine within 2 days preceding the surgery was taken as the preoperative creatinine level. In terms of preoperative medication, we included the following drug classes: angiotensinconverting enzyme inhibitors, angiotensin II receptor blockers, -blockers, calcium channel blockers, insulin, oral hypoglycaemic agents and nitrates.
Vessel harvesting and preparation
Vessel samples from 79 patients were harvested and prepared as described previously (Fonseca et al., 2017b) . Briefly, ITAs were harvested as a pedicle after sternal incision and were externally irrigated with papaverine to prevent vasospasm. Distal portions of ITA discarded from surgery were placed in cold (4 • C) Krebs-Henseleit bicarbonate buffer (mM: 118.7 NaCl, 5.4 KCl, 1.9 CaCl 2 .2H 2 O, 0.9 KH 2 PO 4 , 0.6 MgSO 4 .7H 2 O, 25 NaHCO 3 and 11.1 glucose), previously aerated with 95% O 2 / 5% CO 2 and adjusted to pH 7.4. After harvesting, ITA samples were isolated to remove most of the perivascular tissue.
Vascular reactivity experiments
After isolation, vessels were cut into small rings (3 mm in length) and suspended in tissue organ bath chambers filled with Krebs-Henseleit bicarbonate buffer and maintained at physiological temperature (37 • C) with a thermostat (PanLab, Barcelona, Spain) . In order to record the isometric tension of the rings, these were fixed to a tissuesupporting rod through a platinum wire attached to its mounting hook and then to force transducers (AD Instruments, Oxford, United Kingdom) with a stitching wire attached to another platinum wire.
After several washes, the tension of each ring was adjusted to an optimal resting tension, which corresponded to the equilibrium state achieved after the application of a passive force of 2 g (19.6 mN), and the rings were subsequently allowed to equilibrate and stabilize for 2 h. During this stabilization period, washes were performed each 30 min.
Viability of the vascular rings was assessed with single-dose stimulation of KCl (60 mM) at the beginning and at the end of each experiment. Vasomotion was elicited with noradrenaline (NA; 10 M). After a noradrenaline-induced precontraction, vasodilatation was assessed through cumulative concentration-response curves to Ach (from 10 nM to 1 mM) and sodium nitroprusside (SNP; from 10 nM to 1 mM) to assess the differential influence exerted respectively by the endothelium and the vascular smooth muscle on the occurrence of vasomotion. Vasodilatation was assessed 6 min after precontraction, as a longer period could be a confounding variable in the response owing to spontaneous time-dependent dissipation of the contraction (Rosenfeldt, He, Buxton, & Angus, 1999) .
Statistical analysis
Data are generally presented as means ± SD for continuous variables and as frequencies and percentages for categorical variables; n indicates the number of patients.
The contractile response to KCl and NA was expressed in terms of absolute contraction (in millinewtons). As mentioned earlier, vasodilatation was assessed by cumulative concentration-response curves to ACh and SNP, respectively. The results were expressed as a percentage of the maximal contraction in reponse to NA. From these curves, we extracted the following: (i) the maximal relaxation (i.e. maximal percentage of reduction of the precontraction to NA) or R max parameter; and (ii) the negative logarithm of the molar concentration of vasodilator required to achieve 50% of the maximal relaxation (pIC 50 ), as a parameter of potency. In addition, we also extracted the area under the curve (AUC), i.e. area from the curve obtained by nonlinear regression to a baseline of 0%, which has been suggested previously as a combined measure of efficacy and potency (Fallahi-Sichani, Honarnejad, Heiser, Gray, & Sorger, 2013) .
The individual correlation of each independent variable with the dichotomous dependent variable vasomotion was first studied by the univariate analysis using: (i) Student's t test for independent samples or the Mann-Whitney U test for continuous variables; or (ii) the 2 test or the Fisher's exact test for categorical variables. Variables with a P value of <0.200 were retained for multivariable logistic regression analysis by the forward stepwise method. Owing to a small effective sample size, a P value of <0.100 was chosen for variable retention in the final logistic regression model, which includes the coefficient, the P value, the odds ratio (OR) and the respective 95% confidence interval (CI).
The performance of these multivariable logistic regression models was evaluated considering two properties: (i) the calibration; and (ii) the discriminatory power.
The calibration was assessed by the Hosmer-Lemeshow test, which analyses the differences between the observed and the predicted results. A non-significant P value (P > 0.050) indicates a good calibration of the model (Hosmer & Lemeshow, 2000) . Furthermore, the calibration of the model by decile of predicted risk was also assessed by plotting the predicted versus observed values.
The discriminatory power was evaluated considering the area under the receiver operating characteristic (ROC) curve or AUC ROC (Grunkemeier & Jin, 2001) , which was obtained by the non-parametric approach of Wilcoxon-Mann-Whitney suggested by Hanley and McNeil (1982) . If the AUC ROC is >0.7, we may consider that the model presents a satisfactory discriminatory power (Omar, Ambler, Royston, Eliahoo, & Taylor, 2004) . The R 2 is also presented as a measure of percentage of explanation of the model.
Statistical analysis was performed with IBM SPSS Statistics version 19.0.0 (IBM Corp., Armonk, NY, USA), and graphs were prepared with GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA).
Drugs used
All chemicals were purchased from Sigma-Aldrich (St Louis, MO, USA) and were of the highest grade commercially available.
RESULTS
Incidence and characterization of vasomotion
In our study, vasomotion occurred as oscillatory changes in vascular wall tension (Figure 1a) , and the incidence was 29.1% (n = 23). Vasomotion was elicited in several rings by NA (10 M) but not by KCl (60 mM). Furthermore, ACh and SNP did not abolish vasomotion in some of the vessel rings (Figure 1b, c) . For standardization purposes, no distinction was made among patterns of rhythmic contractions, and two groups were considered: vasomotion and control.
Vasomotion and vessel reactivity
As can be seen in Figure 1e , f and Table 1 , the vasomotion group presented a significantly higher maximal response to both KCl and NA. Also, the contractility ratio, i.e. the ratio between the maximal response to NA and the maximal response to KCl, was significantly higher in the vasomotion group (108.70 ± 48.62% versus 61.88 ± 62.97% in control conditions, P = 0.002), as presented in Figure 1g . Considering the maximal response to KCl as the reference for maximal contractility of a vascular tissue, our results also showed that the mean maximal contraction in response to NA in the vasomotion group was >100% (Figure 1f ).
Regarding vasodilatation, both the endothelium-dependent and the endothelium-independent responses were tested through cumulative concentration-response curves to ACh and SNP, respectively. No significant differences were observed in terms of vasodilatation between vasomotion and control groups, although a generally higher vasodilatory response was seen in the vasomotion group (Table 1) .
Multivariable analysis
The baseline demographics and clinical characteristics and the preoperative medication data of the population are shown in Table 2 , (f) Contractile response to KCl (60 mM; *P < 0.05 versus control). (g) Contractility ratio (%), i.e. NA E max /KCl E max (**P < 0.01 versus control). (h) Predicted probability according to sex (Student's unpaired t test: P < 0.0001). (i, j) Predicted probability according to estimated glomerular filtration rate (eGFR; i) and maximal contractile response to NA (j) and influence of sex, plotted with linear regression and respective 95% confidence interval bands (shaded areas). Correlation estimates in g, h and i correspond to Pearson's r and significance values overall and stratified according to vasomotion response. Compared with the control, the vasomotion group was characterized by a higher mean age, a lower proportion of males and a lower eGFR. Additionally, we found no significant difference between the groups regarding preoperative medication.
Considering the multiplicity of cardiovascular risk factors, we primarily correlated the occurrence of vasomotion with these variables through multivariable logistic regression analysis. As can be seen in Table 3 (model A), the analysis showed an association between vasomotion and the following factors: increasing age and female sex. Values are expressed as means ± SD. AUC, area under the curve; E max , maximal contractile response; pIC 50 , negative logarithm of the molar concentration of vasodilator required to achieve 50% of the maximal relaxation; R max , maximal relaxation.
and the predicted results, although a good fit was not observed between observed and predicted values in risk deciles (Figure 2) . Nevertheless, the model presented a good discriminatory power, as the ROC curve for the vasomotion risk model (Figure 2 ) retrieved an AUC ROC of 0.759, which is higher than the threshold of 0.700 proposed by Omar et al. (2004) .
Given that the vasomotion group presented a significantly higher response to vasoconstrictors, we then included the reactivity parameters in the multivariable analysis (Table 3 , model B). As shown, the association between vasomotion and female sex (odds ratio of 9.82) was the only retained from model A (Figure 1h) . Moreover, the occurrence of vasomotion was independently associated with the maximal response to NA, i.e. the risk of vasomotion increases 1.19 times per 1 mN increase in NA maximal response. As can be seen in Figure 1j , the relationship between these two variables appears to be linear (P < 0.0001). However, the increase in eGFR was associated with the decrease in vasomotion risk (odds ratio of 0.97; Figure 1i Moreover, results from both model A and model B suggested that female sex was an independent predictor of vasomotion. However, a low number of female patients was present in both vasomotion and control groups. Therefore, we performed a multivariable analysis including only male patients and also the reactivity parameters. As presented in model C (Table 3) , both the kidney function (odds ratio of 0.97) and the maximal response to NA (odds ratio of 1.20, per 1 mN increase) were maintained as independent predictors, similar to model B. Diabetes mellitus was also included in the model, although the association was not statistically significant (P = 0.058).
In terms of performance, this model presented Nagelkerke's R 2 of 
DISCUSSION
In our study, the general pattern of vasomotion in the ITA presents similarities to previous reports (Kiss et al., 2011; Peng, Matchkov, Ivarsen, Aalkjaer, & Nilsson, 2001) , although some variability was observed ( Figure 1a) . Also, we confirmed the previous report by Kiss et al. (2011) , who showed vasomotion in the ITA. However, the incidence of vasomotion in our population was markedly lower (29.1 versus 47.8%).
In terms of reactivity, the vasomotion group showed a significantly higher response to both vasoconstrictors, KCl and NA (Figure 1e , f and Table 1 ), although no significant differences were seen in terms of vasodilatation.
In terms of baseline characteristics (Table 2) , the vasomotion group presented a higher age, a higher number of female individuals and a lower mean eGFR. The comparison of medication in both groups returned no difference (Table 2) .
Based on cardiovascular risk factors, the multivariable analysis (Table 3 , model A) identified increasing age and female sex as risk factors for vasomotion. However, as the vasomotion group presented a significantly higher response to vasoconstrictors, we then included the reactivity parameters in the multivariable analysis (Table 3, to NA were maintained when we isolated the male population (Table 3, model C).
Both female sex and eGFR have previously been associated with changes in vascular reactivity and function, including changes in the ITA (Fonseca et al., 2014 (Fonseca et al., , 2017a .
Regarding female sex, DeFelice and Joiner (1975) previously showed that in the presence of high circulating levels of female sex hormones (e.g. oestrogens or prolactin) there is increased responsiveness of isolated rat aortic strips to catecholamines (e.g. adrenaline). Moreover, impaired mRNA expression of endothelial nitric oxide synthase has also been shown previously in ITAs from postmenopausal women, who are typically older women (Mannacio et al., 2012) . This could subsequently lead to impairment of endothelial production of nitric oxide and other endothelium-derived vasodilators, and thus higher response to vasoconstrictors. However, the evidence is not consensual, as some authors have shown no influence of sex on vascular smooth muscle cell contraction and [Ca 2+ ] i variations attributable to Ca 2+ release from intracellular stores (Murphy & Khalil, 2000) , despite sex-specific differences in vascular smooth muscle cell contraction and protein kinase C activity in aortic strips of spontaneously hypertensive rats (Kanashiro & Khalil, 2001; Murphy & Khalil, 2000) . From our results, an association was observed between female sex and a considerably higher risk of vasomotion (Table 3, model B) thus suggesting that this phenomenon might be associated with vascular dysfunction.
Concerning eGFR, Kinoshita et al. (2017) recently showed that the ITA endothelial function with release of nitric oxide may be impaired at the time of surgery in patients with chronic kidney disease, suggesting a potential impact of this clinical setting on the peripheral vasculature. Moreover, this research group has also shown that chronic kidney disease may be associated with intimal hyperplasia of the ITA (Kinoshita, Asai, Suzuki, & Van Phung, 2014) . In our study, increasing eGFR was associated with a lower risk of vasomotion.
Thus, impaired kidney function, which has been associated with endothelial dysfunction, might also be associated with an increase in the occurrence of vasomotion.
Moreover, the occurrence of vasomotion was independently associated with the increase in maximal response to NA (odds ratio of 1.19, per 1 mN increase), thus suggesting that this phenomenon might be linked to the -adrenoceptor signalling of the ITA. Interestingly, previous reports suggested that the 1 -adrenoceptormediated contraction (predominant in the ITA; Bevilacqua et al., 1991) may involve a feedback control mechanism of endothelial nitric oxide production that might be involved in the control of the magnitude of the contractile response (Dora, Doyle, & Duling, 1997; Straub et al., 2011) . Hence, endothelial impairment may result in increased contractile response to agonists of these receptors, namely phenylephrine and NA. In our study, ITA samples generally exhibited endothelial dysfunction, observable as a mean maximal relaxation of 17.31 ± 4.78% to ACh (Table 1) . Therefore, an increase in magnitude of the contractile response to NA might be related to the degree of this endothelial dysfunction, as no significant differences were observed in terms of vasodilatation between vasomotion and control groups.
Thus, these results also support the assumption that vasomotion may be a sign of vascular function impairment.
Some study limitations should be noted. Regarding the methods:
(i) a potential bias in identifying vasomotion should be recognized owing to the wide definition that was used and to the fact that no distinction was made between different patterns of vasomotion;
(ii) the use of several concentrations of NA could indicate the range of concentrations that promotes vasomotion; (iii) only ACh and SNP were used as vasodilators, thus the use of other types of vasodilators with distinct mechanisms of action could provide better insight into the mechanisms involved; and (iv) in the present study, we did not evaluate either the intracellular Ca 2+ flux or the ion conductances, thus mechanistic insight is limited. With regard to the clinical variables identified as independent predictors for vasomotion occurrence: (i) the association with female sex as a risk factor for vascular dysfunction is potentially limited owing to a low number of females and to the lack of evidence of higher incidence of vascular dysfunction in postmenopausal women compared with age-matched men; and (ii) an association with impaired kidney function is limited, in spite of the results from the multivariable analysis, because a possible confounding effect of age, which was significantly higher in the vasomotion group, should not be neglected. Furthermore, the correlation between vasomotion and the follow-up data of this population (e.g. mortality or graft patency) could permit a deeper understanding of the physiological relevance of this phenomenon.
In conclusion, our results suggest that vasomotion may be associated with endothelial dysfunction settings and might therefore be a signal of impairment and not integrity. Thus, the assumption that vasomotion could be a physiological mechanism that contributes to optimal blood flow and tissue perfusion remains to be confirmed.
